Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs (Q58043487)
Jump to navigation
Jump to search
scientific article published on 01 December 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs |
scientific article published on 01 December 1997 |
Statements
Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs (English)
T Lichtinger
J Schölmerich
H Menninger
B Lang
U Müller-Ladner
1 December 1997